Titan Pharmaceuticals (NASDAQ:TTNP) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report sent to investors on Saturday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance TTNP stock opened at $0.52 on Friday. Titan Pharmaceuticals has a twelve month low of $0.43 and […]

Related Keywords

United States ,Canada ,Davide Lazar , ,Titan Pharmaceuticals Stock Performance ,Renaissance Technologies ,Titan Pharmaceuticals ,Titan Pharmaceuticals Inc ,Insider Activity At Titan Pharmaceuticals ,European Union ,Institutional Investors Weigh In On Titan Pharmaceuticals ,Virtu Financial ,Titan Pharmaceuticals Company Profile ,Millennium Management ,News Ratings For Titan Pharmaceuticals Daily ,Securities Exchange Commission ,Free Report ,Get Free Report ,Exchange Commission ,Street Corp ,Titan Pharmaceuticals Daily ,Nasdaq Ttnp ,Ttnp ,Medical ,Initiated Coverage ,Stocknews Com ,